Vincent Richard G's Form 4 filing
Oncternal Therapeutics, Inc. (ONCT) · filed Mar 28, 2022
- Accession no.
- 0001209191-22-021302
- Filed
- Mar 28, 2022
- Trade date
- Mar 24-28, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market purchases total $7.21K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vincent Richard GCIK 0001269341 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2022 | Common Stock | PPurchaseAcquired | +3 | $1.45 | +$4.35 | 83,165 | Direct | |
| Mar 25, 2022 | Common Stock | PPurchaseAcquired | +356 | $1.45 | +$516.2 | 83,521 | Direct | |
| Mar 25, 2022 | Common Stock | PPurchaseAcquired | +5 | $1.48 | +$7.4 | 83,526 | Direct | |
| Mar 25, 2022 | Common Stock | PPurchaseAcquired | +2,136 | $1.49 | +$3,182.64 | 85,662 | Direct | |
| Mar 28, 2022 | Common Stock | PPurchaseAcquired | +2,500 | $1.40 | +$3,500 | 88,162 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.